Collection
COVID-19/SARS-CoV-2
- Submission status
- Open
- Open for submission from
- 12 August 2022
- Submission deadline
- Ongoing
A collection of recent articles related to COVID-19/SARS-CoV-2
Articles (8 in this collection)
-
-
Exploring the Use of Monoclonal Antibodies and Antiviral Therapies for Early Treatment of COVID-19 Outpatients in a Real-World Setting: A Nationwide Study from England and Italy
Authors (first, second and last of 10)
- Francesco Ciccimarra
- Nicoletta Luxi
- Gianluca Trifirò
- Content type: Original Research Article
- Open Access
- Published: 06 May 2023
- Pages: 675 - 684
-
Tolerability and Reactogenicity Profile of mRNA SARS-Cov-2 Vaccines from a Mass Vaccination Campaign in a Tertiary Hospital: Between-Vaccine and Between-Population Prospective Observational Study (VigilVacCOVID Study)
Authors (first, second and last of 15)
- Joaquín Sáez-Peñataro
- Ferran Torres
- the VigilVacCOVID Group
- Content type: Original Research Article
- Open Access
- Published: 28 June 2022
- Pages: 509 - 520
-
Allergic Reactions to COVID-19 Vaccines: Risk Factors, Frequency, Mechanisms and Management
Authors (first, second and last of 15)
- Nicoletta Luxi
- Alexia Giovanazzi
- Gianluca Trifirò
- Content type: Review Article
- Open Access
- Published: 13 June 2022
- Pages: 443 - 458
-
Passive Immunotherapy Against SARS-CoV-2: From Plasma-Based Therapy to Single Potent Antibodies in the Race to Stay Ahead of the Variants
Authors (first, second and last of 6)
- William R. Strohl
- Zhiqiang Ku
- Lila M. Strohl
- Content type: Leading Article
- Open Access
- Published: 27 April 2022
- Pages: 231 - 323
-
SARS-CoV-2 Neutralization in Convalescent Plasma and Commercial Lots of Plasma-Derived Immunoglobulin
Authors (first, second and last of 6)
- Andreas Volk
- Caroline Covini-Souris
- Torben Schmidt
- Content type: Original Research Article
- Open Access
- Published: 29 November 2021
- Pages: 41 - 53
-
Approval of Itolizumab for COVID-19: A Premature Decision or Need of The Hour?
Authors
- Shubham Atal
- Zeenat Fatima
- Sadasivam Balakrishnan
- Content type: Current Opinion
- Published: 13 October 2020
- Pages: 705 - 711
-
Potential Role of Anti-interleukin (IL)-6 Drugs in the Treatment of COVID-19: Rationale, Clinical Evidence and Risks
Authors (first, second and last of 5)
- Salvatore Crisafulli
- Valentina Isgrò
- Gianluca Trifirò
- Content type: Leading Article
- Published: 15 June 2020
- Pages: 415 - 422